These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 27561709

  • 1. Long-term safety and efficacy of bilastine following up to 12 weeks or 52 weeks of treatment in Japanese patients with allergic rhinitis: Results of an open-label trial.
    Okubo K, Gotoh M, Togawa M, Saito A, Ohashi Y.
    Auris Nasus Larynx; 2017 Jun; 44(3):294-301. PubMed ID: 27561709
    [Abstract] [Full Text] [Related]

  • 2. One-year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases.
    Yagami A, Furue M, Togawa M, Saito A, Hide M.
    J Dermatol; 2017 Apr; 44(4):375-385. PubMed ID: 27862227
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
    Kuna P, Bachert C, Nowacki Z, van Cauwenberge P, Agache I, Fouquert L, Roger A, Sologuren A, Valiente R, Bilastine International Working Group.
    Clin Exp Allergy; 2009 Sep; 39(9):1338-47. PubMed ID: 19438584
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo in the treatment of perennial allergic rhinitis.
    Sastre J, Mullol J, Valero A, Valiente R, Bilastine Study Group.
    Curr Med Res Opin; 2012 Jan; 28(1):121-30. PubMed ID: 22077106
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of bilastine in Japanese patients with perennial allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III study.
    Okubo K, Gotoh M, Asako M, Nomura Y, Togawa M, Saito A, Honda T, Ohashi Y.
    Allergol Int; 2017 Jan; 66(1):97-105. PubMed ID: 27421817
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of bilastine in Japanese patients with chronic spontaneous urticaria: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II/III study.
    Hide M, Yagami A, Togawa M, Saito A, Furue M.
    Allergol Int; 2017 Apr; 66(2):317-325. PubMed ID: 27599913
    [Abstract] [Full Text] [Related]

  • 7. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
    Singh-Franco D, Ghin HL, Robles GI, Borja-Hart N, Perez A.
    Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
    [Abstract] [Full Text] [Related]

  • 8. Bilastine: in allergic rhinitis and urticaria.
    Carter NJ.
    Drugs; 2012 Jun 18; 72(9):1257-69. PubMed ID: 22686617
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients.
    Bachert C, Kuna P, Sanquer F, Ivan P, Dimitrov V, Gorina MM, van de Heyning P, Loureiro A, Bilastine International Working Group.
    Allergy; 2009 Jan 18; 64(1):158-65. PubMed ID: 19132976
    [Abstract] [Full Text] [Related]

  • 10. Safety and tolerability of bilastine 10 mg administered for 12 weeks in children with allergic diseases.
    Novák Z, Yáñez A, Kiss I, Kuna P, Tortajada-Girbés M, Valiente R, “Bilastine Paediatric Safety Study Group”.
    Pediatr Allergy Immunol; 2016 Aug 18; 27(5):493-8. PubMed ID: 26918853
    [Abstract] [Full Text] [Related]

  • 11. Safety profile of bilastine: 2nd generation H1-antihistamines.
    Scaglione F.
    Eur Rev Med Pharmacol Sci; 2012 Dec 18; 16(14):1999-2005. PubMed ID: 23242729
    [Abstract] [Full Text] [Related]

  • 12. A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit - the Vienna Challenge Chamber (VCC).
    Stübner P, Zieglmayer R, Horak F.
    Curr Med Res Opin; 2004 Jun 18; 20(6):891-902. PubMed ID: 15200748
    [Abstract] [Full Text] [Related]

  • 13. Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review.
    Bousquet J, Ansótegui I, Canonica GW, Zuberbier T, Baena-Cagnani CE, Bachert C, Cruz AA, González SN, Kuna P, Morais-Almeida M, Mullol J, Ryan DP, Sánchez-Borges M, Valiente R, Church MK.
    Curr Med Res Opin; 2012 Jan 18; 28(1):131-9. PubMed ID: 22149770
    [Abstract] [Full Text] [Related]

  • 14. Bilastine safety in drivers who need antihistamines: new evidence from high-speed simulator driving test on allergic patients.
    Demonte A, Guanti MB, Liberati S, Biffi A, Fernando F, Fainello M, Pepe P.
    Eur Rev Med Pharmacol Sci; 2018 Feb 18; 22(3):820-828. PubMed ID: 29461615
    [Abstract] [Full Text] [Related]

  • 15. Effect of bilastine upon the ocular symptoms of allergic rhinoconjunctivitis.
    Bartra J, Mullol J, Montoro J, Jáuregui I, del Cuvillos A, Dávila I, Ferrer M, Sastre J, Valero A.
    J Investig Allergol Clin Immunol; 2011 Feb 18; 21 Suppl 3():24-33. PubMed ID: 22185047
    [Abstract] [Full Text] [Related]

  • 16. Open-label safety assessment of bilastine in elderly patients with allergic rhinoconjunctivitis and/or urticaria.
    Sologuren A, Viñas R, Cordón E, Riesgo SE, Del Mar Forés M, Senán MR, Fernández S, Labeaga L, Ruiz-Miján M.
    Allergy Asthma Proc; 2018 Jul 20; 39(4):299-304. PubMed ID: 29559031
    [Abstract] [Full Text] [Related]

  • 17. Effect of bilastine upon nasal obstruction.
    Dávila I, Sastre J, Mullol J, Montoro J, Jáuregui I, Ferrer M, del Cuvillo A, Bartra J, Valero A.
    J Investig Allergol Clin Immunol; 2011 Jul 20; 21 Suppl 3():2-8. PubMed ID: 22185044
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of levocetirizine in improving symptoms and health-related quality of life in US adults with seasonal allergic rhinitis: a randomized, placebo-controlled study.
    Segall N, Gawchik S, Georges G, Haeusler JM.
    Ann Allergy Asthma Immunol; 2010 Mar 20; 104(3):259-67. PubMed ID: 20377116
    [Abstract] [Full Text] [Related]

  • 19. The Impact of Bilastine on Symptoms of Allergic Rhinitis and Chronic Urticaria: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Abdelshafy AM, Abdallah SY, Hassan AF, Mohamed HA, Kamal NM, Ali ST, Abdelhaleem IA.
    Am J Rhinol Allergy; 2022 Sep 20; 36(5):684-694. PubMed ID: 35593100
    [Abstract] [Full Text] [Related]

  • 20. Rapid symptom relief in rhinitis.
    Bousquet J.
    Clin Exp Allergy; 1999 Mar 20; 29 Suppl 1():25-9. PubMed ID: 10209702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.